Janus Henderson Group PLC Revolution Medicines, Inc. Transaction History

Janus Henderson Group PLC

$207 Billion
Q3 2025

A detailed history of Janus Henderson Group PLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 11,356,054 shares of RVMD stock, worth $769 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

11,356,054

Previous 10,590,727 7.23%

Holding current value

$769 Million

Previous $390 Million 36.11%

% of portfolio

0.26%

Previous 0.2%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$34.7 - $46.7 $26.6 Million - $35.7 Million	765,327 Added 7.23%	11,356,054 $530 Million
Q2 2025 Aug 14, 2025	BUY	$31.13 - $41.98 $12.5 Million - $16.8 Million	400,656 Added 3.93%	10,590,727 $390 Million
Q1 2025 May 15, 2025	BUY	$35.36 - $44.42 $25 Million - $31.4 Million	706,072 Added 7.44%	10,190,071 $360 Million
Q4 2024 Feb 14, 2025	BUY	$42.97 - $60.6 $144 Million - $203 Million	3,346,755 Added 54.53%	9,483,999 $415 Million
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $55.3 Million - $71.8 Million	1,497,026 Added 32.26%	6,137,244 $278 Million
Q2 2024 Aug 14, 2024	BUY	$30.14 - $40.68 $21.9 Million - $29.6 Million	728,099 Added 18.61%	4,640,218 $180 Million
Q1 2024 May 15, 2024	BUY	$26.56 - $33.55 $45.5 Million - $57.5 Million	1,712,639 Added 77.87%	3,912,119 $126 Million
Q4 2023 Feb 14, 2024	SELL	$18.35 - $34.12 $757,102 - $1.41 Million	-41,259 Reduced 1.84%	2,199,480 $63.1 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $23.2 Million - $32.3 Million	922,897 Added 70.03%	2,240,739 $62 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $19.6 Million - $26.1 Million	965,014 Added 273.51%	1,317,842 $35.3 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $7.13 Million - $10.3 Million	343,212 Added 3569.18%	352,828 $7.64 Million
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $170,010 - $245,496	9,616 New	9,616 $229,000
Q2 2022 Aug 15, 2022	SELL	$14.54 - $27.17 $140,572 - $262,679	-9,668 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $34 - $52	2 Added 0.02%	9,668 $246,000
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $235,367 - $325,744	9,666 New	9,666 $243,000

Others Institutions Holding RVMD

# of Institutions

356

Shares Held

195M

Call Options Held

2.66M

Put Options Held

945K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $5.94B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Revolution Medicines, Inc. Transaction History